June 25, 2013
Fitch Even partner Kendrew H. Colton was quoted in an article published June 17, 2013, in the online and print editions of Chemical & Engineering News, a weekly publication of the American Chemical Society. The article, titled "High Court Nixes Gene Patents," reports on the recent U.S. Supreme Court decision in Association for Molecular Pathology et al. v. Myriad Genetics, Inc., et al, a case addressing the question of whether human genes are patent-eligible subject matter.
Ken has extensive intellectual property counseling and litigation experience involving patent infringement, contract licensing disputes, copyrights, unfair competition, and trade secrets. He is a member of the Executive Committee of the Chemistry and the Law Division (CHAL) of the American Chemical Society and a member of the Chemical & Engineering News Advisory Board .
- IP Alert | USPTO Releases Latest Guidance for Evaluating Subject Matter Eligibility Under 35 U.S.C. § 101January 11, 2019 Read more
- IP Alert | USPTO Releases Guidance for Examining Computer-Implemented Functional Claim Limitations for Compliance with 35 U.S.C. § 112January 11, 2019 Read more